---
layout: default
title: Votrient
cite: pazopanib
prevlink: /2011/06/20/tyverb.html
nextlink: /2011/05/07/fraxi.html
---

                <section id="portfolio">{% include arrows.html %}
                    <div class="portfolio post">
                        <h2>Portfolio</h2>
                        <h3>Votrient <cite>pazopanib</cite></h3>
                        <p class="translate translate-en">Pazopanib (trade name Votrient) is a potent and selective multi-targeted receptor tyrosine kinase inhibitor of VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-a/β, and c-kit that blocks tumor growth and inhibits angiogenesis. New version of the site.</p>
                        <p class="translate translate-pl">Pazopanib (nazwa handlowa Votrient) jest silnym i selektywnym wielo-ukierunkowanym receptorowym inhibitorem kinazy tyrozynowej VEGFR-1, VEGFR-2, VEGFR-3, PDGFR-a/β i c-kit, który blokuje wzrost guza i hamuje angiogenezę. Nowa wersja strony.</p>
                        <ul class="technologies">
                            <li><abbr title="eXtensible HyperText Markup Language">XHTML</abbr> 1.1</li>
                            <li><abbr title="Cascading Style Sheets">CSS</abbr> 2.1</li>
                            <li class="last"><abbr title="JavaScript">JS</abbr></li>
                            <li class="date"><span class="jun">Jun</span> 2011</li>
                            <li class="preview"><a href="/votrient20/" target="_blank">See preview</a></li>

                        </ul>
                        <img src="/images/posts/votrient20.jpg" alt="Preview" class="preview" />
                    </div>
                    <!-- / post item -->
                </section>
                <!-- / portfolio -->
